Blended learning for entrepreneurial biomedical professionals

Paul Janssen Futurelab Leiden is an international blended learning (online and on-campus) program for entrepreneurial biomedical professionals.

profile of CD online March 25

The next course Clinical Development starts on March 25, 2019

Learn more

profile of Spotlight interviews

What drives our course participants and alumni?

Read the interview

On campus

Experience the on-campus

For four days, you will further explore question-based development in the beautiful setting of the castle and hotel Oud-Poelgeest. With a small group of maximum 30 course participants, you will reside at the castle and examine teaching cases that are based on real events. In “what really happened” sessions, invited speakers discuss the actual choices that were made during the case.


Read more

A selection of our contributors

Henk Schuring

Henk Schuring

VP-Head Rare Nephrology
Sanofi Genzyme

Sjaak Bot

Sjaak Bot

VP, Head of EMEA Regulatory Affairs
Janssen

Bernd van der Meulen

Bernd van der Meulen

Professor of Comparative Food Law
European Institute for Food Law / Renmin University of China Law School

Frank Landolt

Frank Landolt

V.P. intellectual property and legal
Ablynx N.V.

Erik Niks

Erik Niks

Neurologist - Pediatric neurologist
Leiden University Medical Center

Piet Hinoul

Piet Hinoul

Global Head, Pre-Clinical, Clinical and Medical Affairs
J&J Ethicon

Ad Sitsen

Ad Sitsen

Owner
ClinPharMed Consultancy for Drug Development

Wim Parys

Wim Parys

Head of R&D Global Public Health
Janssen Pharmaceutica

Eline Bunnik

Eline Bunnik

Assistant professor Medical Ethics and Philosophy of Medicine
Erasmus MC

Maurits Westerik

Maurits Westerik

Senior Counsel
Bird & Bird

Andrea Kamage

Andrea Kamage

Patent Group Leader
Johnson & Johnson

Bart Swinkels

Bart Swinkels

Partner
NLO

Karin Verzijden

Karin Verzijden

Food and Pharma Lawyer
Axon Lawyers

Ineke Jonker-Hoogerkamp

Ineke Jonker-Hoogerkamp

Consultant Regulatory Affairs and Drug Development
Eagle Pharma Consult

Kees Recourt

Kees Recourt

Investment Manager
Mibiton Foundation

Paul Stoffels

Paul Stoffels

Chief scientific officer
Johnson & Johnson

Tom Huizinga

Tom Huizinga

Head of the Department of Rheumatology
Leiden University Medical Centre

Marcel Kenter

Marcel Kenter

Director
Paul Janssen Futurelab Leiden

Koen Andries

Koen Andries

VP Scientific Fellow Infectious Diseases Discovery
Janssen Pharmaceutica NV

Andreas Wallnöfer

Andreas Wallnöfer

General Partner
BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)

Justin Hay

Justin Hay

Pharmacokinetics Assessor
Medicines and Healthcare products Regulatory Agency

André Elferink

André Elferink

Clinical epidemiologist
Dutch Medicines Evaluation Board

Rob Zuiker

Rob Zuiker

Senior Clinical Scientist
CHDR

Barbara J. van Zwieten-Boot

Barbara J. van Zwieten-Boot

Vice Chair
Medicines Evaluation Board, The Netherlands

Hans-Georg Eichler

Hans-Georg Eichler

Senior Medical Officer
European Medicines Agency

Robert Klautz

Robert Klautz

Thoracic Surgeon
Leiden University Medical Centre

Matthijs Moerland

Matthijs Moerland

Research Director Translational Biomarkers
CHDR

Joris Rotmans, MD, PhD

Joris Rotmans, MD, PhD

internist-nephrologist
LUMC

Janneke Meulenberg

Janneke Meulenberg

CEO
Arthrogen

Inge de Lepeleire

Inge de Lepeleire

Director Translational Pharmacology
MSD Europe

Koos Burggraaf

Koos Burggraaf

Research Director CVS & Metabolism
CHDR

Johan Garssen

Johan Garssen

Director Immunology Platform
Danone/Nutricia Research

Ingrid de Visser

Ingrid de Visser

Senior Clinical Scientist
CHDR

Rick Kuntz

Rick Kuntz

Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Medtronic

Geert Jan Groeneveld

Geert Jan Groeneveld

Research Director CNS
CHDR

Oliver Bisazza

Oliver Bisazza

Director Regulatory Policy
Medtronic

Saco de Visser

Saco de Visser

Head of Education and Clinical Pharmacologist
Paul Janssen Futurelab Leiden

Adam Cohen

Adam Cohen

CEO and clinical pharmacologist
Centre for Human Drug Research

Richard Shull

Richard Shull

Head of Deal Structuring and Trading Fundamentals
Shell

Pierre Peeters

Pierre Peeters

Former site head early stage development
Organon

Our approach in professional learning

We offer a unique blend of online education and on-campus training for talented biomedical scientist that have the ambition to become the future generation Chief Scientific Officers.

Stay connected

Quote Paul Janssen Futurelab

Interesting insights

“Very nice approach, all cases were well explained in the provided papers and the interviews always gave interesting insights”

Pierre-Eric Juif, Actelion, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Not the traditional classroom

"Clinical development was dissected in a different way than I am used to, which was intriguing. The interface of the online course and exam were really nice: simple and straightforward to interact with, at your own pace and time, and you can go back and forth as you wish, certainly not the traditional way of a frontal classroom interface!”

Ofer Spiegelstein, Teva Pharmaceutical Industries Ltd, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Very helpful

"The cases were very helpful, they brought the theory to life!"

Dennie Tempel, Quorics B.V., Clinical Development Online graduate

Quote Paul Janssen Futurelab

A world of knowledge

"This training opened my eyes to a whole new world of knowledge on the development of medical interventions"

Willem Birkhoff, Centre for Human Drug Research, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Really instructive

"The highlights of the course were the real life examples and the follow up provided. The interviews with people that were involved in the studies were really instructive"

Georges Habineza Ndikuyeze, Janssen Research & Development, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Out of my comfort zone

“I loved the ‘corporate finance’ bit, really out of my comfort zone, but it did give me so much more insight into the financial considerations in clinical development”

Meta Roestenberg, Leiden University Medical Center, Clinical Development Online graduate

Recent tweets

Meet part of our team at the @BritPharmSoc event in London (18-20 Dec). In collaboration with @CHDR_NL we are presenting TRC2.0: an interactive tool for medical and biopharmaceutical students.

Twitter image

Is it time to change the EU regulations on Gene Therapy? Interview with Gerard Schouw (VIG), Sander van Deventer (Uniqure) and Marcel Kenter (PJ Futurelab) https://t.co/jDWJ0v0VPH https://t.co/jDWJ0v0VPH

Twitter image

We are at capacity for tomorrow's free Futurelab Talks on Market Approval. If you are still interested to come, please send an email to contact@pauljanssenfuturelab.eu for any last minute spots. https://t.co/yMOqJjmNjM

Twitter image

First #JLABS incubator in EU is open for business https://t.co/Xqn3md0Sgs